SCHEMBL29655874

SCHEMBL29655874

CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]1CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC1=O)[C@@H](C)CC)[C@@H](C)O

nearest known ligand 0.60

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
F11 P03951 1/20 0.60
MSTN O14793 1/20 0.59
GLP1R P43220 4/20 0.59
PRLHR P49683 2/20 0.57
NR3C1 P04150 1/20 0.56
NPY2R P49146 2/20 0.55
IL23R Q5VWK5 2/20 0.55
BECN1 Q14457 2/20 0.54
NPFFR2 Q9Y5X5 1/20 0.54
KEAP1 Q14145 1/20 0.54
ESR1 P03372 1/20 0.54
ESR2 Q92731 1/20 0.54
PTH1R Q03431 2/20 0.54
CCKBR P32239 1/20 0.54
MDM2 Q00987 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29358496 0.86 GLP1R (0.68) GLP1RNR3C1NPY2RIL23RKEAP1
SCHEMBL29754464 0.81 IL23R (0.64) GLP1RIL23R
SCHEMBL29383537 0.80 GLP1R (0.74) GLP1RNR3C1NPY2RPTH1RCCKBR
SCHEMBL29913332 0.79 GLP1R (0.74) GLP1RIL23RPTH1RCCKBR
SCHEMBL29358595 0.79 GLP1R (0.68) GLP1RIL23RPTH1RCCKBR
SCHEMBL29694497 0.79 GLP1R (0.65) GLP1RCCKBR
SCHEMBL31092855 0.79 IL23R (0.67) GLP1RNR3C1NPY2RIL23R
SCHEMBL7358806 0.79 IL23R (0.61) GLP1RIL23RPTH1RCCKBR
SCHEMBL31135025 0.79 PTH1R (0.68) GLP1RPTH1R
SCHEMBL30506350 0.79 GLP1R (0.68) GLP1RNPY2RCCKBR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12473522-B2 Methods and systems for cell labeling and imaging CELLFE, INC. (US) 2025-11-18 US disclosed
US-12391976-B2 Methods, kits, and compositions for processing extracellular molecules 10X GENOMICS, INC. (US) 2025-08-19 US disclosed
US-20240150812-A1 METHODS, KITS, AND COMPOSITIONS FOR PROCESSING EXTRACELLULAR MOLECULES 10X GENOMICS, INC. 2024-05-09 US disclosed
US-11851700-B1 Methods, kits, and compositions for processing extracellular molecules 10X GENOMICS, INC. (US) 2023-12-26 US disclosed
US-20230382966-A1 NOVEL KLOTHO INTERACTION SITE IN THE C-TERMINUS OF FGF23 INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION 2023-11-30 US disclosed
US-20230235357-A1 MICROFLUIDIC LASER-ACTIVATED INTRACELLULAR DELIVERY SYSTEMS AND METHODS CELLINO BIOTECH INC (US) 2023-07-27 US disclosed
US-20220298461-A1 METHODS AND SYSTEMS FOR CELL LABELING AND IMAGING CELLFE, INC. (US) 2022-09-22 US disclosed
US-20220213422-A1 METHODS AND SYSTEMS FOR INTRACELLULAR DELIVERY AND PRODUCTS THEREOF CELLFE, INC. (US) 2022-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230382966-A1 NOVEL KLOTHO INTERACTION SITE IN THE C-TERMINUS OF FGF23 FGF23, PTH1R, PTMS F11 1247/4885MSTN 65/4885GLP1R 114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.